We can buy this stock at 3,00$, Lexaria Bioscience Corp, with address at 740 MCCURDY ROAD SUITE 100, KELOWNA, British Columbia, V1X 2P7, Canada, is a publicly traded company and its visible heads at the moment are Christopher A. Bunka (Chairman & Chief Executive Officer), John Martin Docherty (President & Director). Focused on Biotechnology: Pharmaceutical Preparations was created long ago in Canada.
The closing price of the stock yesterday was desconocido$.
The current range on the same day is from 2,95$ - 3,53$, with a percentage difference of 3,24$ quite wide that helps to be able to do day trading.
The company has an annual revenue of desconocido.
The last value we have registered for the opening is desconocido.
To detect if it is a good time to enter or exit a stock, many traders use the lowest and highest values of the last 52 weeks. In this action, prices have moved between 0,00$ and 0,00$.
Earnings per share, or EPS, is a value also used to assess whether a company has obtained sufficient net profits for the number of shares it has for sale. In this case it is [BPA], but it must be taken into account that there may have been increases or decreases in capital that influence the value.
Buscar
